Trial · NCT03048747
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day2 | 43.8 | percentage of participants | |
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day3 | 80 | percentage of participants | |
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day4 | 80 | percentage of participants | |
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day5 | 85.7 | percentage of participants | |
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day7 | 92.9 | percentage of participants | |
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day14 | 83.3 | percentage of participants | |
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day21 | 81.8 | percentage of participants | |
| Percentage of Subjects With Normalized Serum Sodium Concentration on the Day After Final IMP Administration | Tolvaptan | Day after final study medication | 81.3 | percentage of participants | |
| Change in Serum Sodium Concentration | Tolvaptan | Day2 | 6.9 | Standard Error 2.6 | mEq/L |
| Change in Serum Sodium Concentration | Tolvaptan | Day3 | 8.1 | Standard Error 3.8 | mEq/L |
| Change in Serum Sodium Concentration | Tolvaptan | Day4 | 8.5 | Standard Error 4.6 | mEq/L |
| Change in Serum Sodium Concentration | Tolvaptan | Day5 | 8.8 | Standard Error 4.4 | mEq/L |
| Change in Serum Sodium Concentration | Tolvaptan | Day7 | 10.0 | Standard Error 4.5 | mEq/L |
| Change in Serum Sodium Concentration | Tolvaptan | Day14 | 10.8 | Standard Error 3.7 | mEq/L |
| Change in Serum Sodium Concentration | Tolvaptan | Day21 | 10.4 | Standard Error 6.0 | mEq/L |
| Change in Serum Sodium Concentration | Tolvaptan | Day after final study medication | 11.0 | Standard Error 4.3 | mEq/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03048747/results